Objectives: To investigate the role of a preoperative modified frailty index (mFI) based on data from medical records in predicting postoperative complications among older Chinese patients with hip fractures. Methods: This retrospective cohort study included consecutive older patients with hip fracture admitted to the Department of Orthopaedics, West China Hospital, Sichuan University, from December 2010 to June 2017 who underwent surgical repair. We selected 33 variables, including characteristics of hip fracture, to construct a mFI. Each variable was coded with a value of 0 when a deficit was absent or 1 when it was present. We calculated the mFI as the proportion of positive items and defined frailty as mFI value greater than or equal to 0.21 according to threshold proposed by Hoover et al. We examined the relationship between mFI and severity of postoperative complications and the occurrence of in-hospital pneumonia including statistical adjustment for several demographics (e.g. age, gender, and marital status) and habits (smoking and alcohol intake), time from fracture to surgery in the multivariable model. Results: We included 965 patients (34% male; mean age: 76.77 years; range: 60 to 100 years) with a prevalence of frailty of 13.06%. The presence of frailty was associated with a higher severity of complications (OR: 2.07; 95% CI: 1.40 to 3.05). Frail patients were more likely to develop in-hospital pneumonia than non-frail patients (OR: 2.08; 95% CI: 1.28 to 3.39). Conclusion: The preoperative modified frailty index based on data from medical records proved significantly associated with postoperative complications among older patients with hip fractures undergoing hip surgery.
1 February 2022 in Journal of Clinical Epidemiology
Background/Objectives: Chronic obstructive pulmonary disease (COPD) is characterized by persistent symptoms and fluctuating disease status. Effective COPD management requires not only alleviating symptom burden but also maintaining disease stability. An integrated management strategy added to usual care, combining adjunctive acupuncture for symptom control with electronic patient-reported outcome (ePRO)-guided symptom monitoring and timely clinical responses, may provide a novel approach to optimize COPD care. This trial will evaluate whether this management strategy can improve long-term COPD outcomes compared with usual care alone. Methods: This is an open-label, randomized controlled trial with blinded outcome assessments. A total of 172 patients with stable COPD will be randomized 1:1 to usual care or intervention group. The intervention consists of an initial symptom-control phase followed by an ePRO-guided monitoring and response phase with predefined clinical management adjustments. We will follow up participants for 12 months and collect data every 2 months to assess hospitalization, exacerbations, mortality, health status and safety. All analyses will adhere to the intention-to-treat principle. The primary outcome (i.e., time to first COPD-related hospitalization) will be analyzed using a cause-specific Cox proportional hazards model, with death before hospitalization treated as a competing event. The cumulative incidence of COPD-related hospitalization will be estimated using the Aalen–Johansen estimator. Conclusions: This study will evaluate, compared with usual care alone, whether an integrated ePRO-guided COPD management strategy incorporating adjunctive acupuncture could provide additional benefits. As this is the first trial of this integrated intervention, the findings should be considered preliminary and cannot determine the separate effects of the individual components. This study may provide a patient-centered management model for COPD and inform future exploration of integrative care.